Coverage dated January 26, 2025

Novo Nordisk agrees to cap insulin price, give drug for free to neediest Minnesotans

Headline from Alexandria Echo Press

A settlement Monday means free insulin for Minnesotans at or below 400% of the poverty line and for an out-of-pocket cap of $35 per monthly prescription, regardless of insurance, when paid in cash

Alexandria Echo Press's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

8 articles, oldest first.

  1. Alexandria Echo Press

    Novo Nordisk agrees to cap insulin price, give drug for free to neediest Minnesotans (opens Alexandria Echo Press)

    Published

    Alexandria Echo Press's feed description

    A settlement Monday means free insulin for Minnesotans at or below 400% of the poverty line and for an out-of-pocket cap of $35 per monthly prescription, regardless of insurance, when paid in cash

  2. Quartz

    Novo Nordisk agrees to cap insulin prices in Minnesota settlement (opens Quartz)

    Published

    Quartz's feed description

    The recent settlement requires Novo Nordisk to cap monthly insulin costs at $35

  3. Minneapolis Star Tribune

    Latest pharma lawsuit settlement expands low-cost insulin to more Minnesotans (opens Minneapolis Star Tribune)

    Published

    Minneapolis Star Tribune's feed description

    Novo Nordisk is the third major U.S. manufacturer of insulin to settle a price-fixing lawsuit by the state of Minnesota and keep costs of insulin at $35 per month for the next five years.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Novo Nordisk agrees to cap insulin price, give drug for free to neediest Minnesotans | Since Then